Literature DB >> 1700210

Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium.

P M Tande1, H Bjørnstad, T Yang, H Refsum.   

Abstract

The electromechanical effects of UK-68,798 (UK), a novel class III antiarrhythmic drug, were studied in guinea pig and rat papillary muscles (PMs) and atria in vitro using conventional microelectrode technique. UK (10(-8)-10(-6) M) prolonged the action potential duration (APD) by 21-58% and effective refractory period in parallel, without affecting the resting potential or maximum rate of depolarization in guinea pig PM stimulated at 1 Hz. UK increased the contractile force without prolonging the time to peak force or relaxation. In comparison, 5 x 10(-5) M d-sotalol was needed to induce the same electrophysiological effects as 10(-8) M UK. UK prolonged the APD significantly less at 2 Hz than at 1 and 0.5 Hz. Early afterdepolarizations (EADs) developed in 2 of 11 preparations after 10(-6) M at 0.5 Hz. No reversal of drug effect was seen after up to 2 h washout. UK (10(-9)-10(-5) M) reduced the spontaneous heart rate and prolonged the sinus node recovery time of guinea pig right atria. No effects on rat PM or atria, even after 10(-5) M, indicate a selective action of UK on the delayed rectifying outward potassium current, Ik. These results indicate a potent and selective, rate-dependent class III antiarrhythmic action of UK-68,798 linked with positive inotropy. Increased APD, bradycardia, and induction of EADs, however, represent a potential arrhythmogenic combination.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700210     DOI: 10.1097/00005344-199009000-00008

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  23 in total

1.  Field and action potential recordings in heart slices: correlation with established in vitro and in vivo models.

Authors:  Herbert M Himmel; Alexandra Bussek; Michael Hoffmann; Rolf Beckmann; Horst Lohmann; Matthias Schmidt; Erich Wettwer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

3.  Effects of class III antiarrhythmic drugs on the Na(+)-activated K+ channels in guinea-pig ventricular cells.

Authors:  K Mori; T Saito; Y Masuda; H Nakaya
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  IK independent class III actions of MS-551 compared with sematilide and dofetilide during reperfusion in anaesthetized rats.

Authors:  J Chen; S Komori; B Li; K Tamura; K Hashimoto
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

5.  The positive inotropic effect of compound II, a novel analogue of sotalol, on guinea-pig papillary muscles and single ventricular myocytes.

Authors:  E White; S P Connors; E W Gill; D A Terrar
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

6.  Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block.

Authors:  A Ohler; G J Amos; E Wettwer; U Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

7.  Effects of mitoxantrone on action potential and membrane currents in isolated cardiac myocytes.

Authors:  G X Wang; X B Zhou; T Eschenhagen; M Korth
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

8.  Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle.

Authors:  T Yang; P M Tande; D A Lathrop; H Refsum
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

9.  Importance of vagally mediated bradycardia for the induction of torsade de pointes in an in vivo model.

Authors:  A Farkas; J Dempster; S J Coker
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

10.  Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo.

Authors:  A Bril; L Landais; B Gout
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.